메뉴 건너뛰기




Volumn 55, Issue 1, 2009, Pages 237-239

Treatment with Sunitinib Enabled Complete Resection of Massive Lymphadenopathy not Previously Amenable to Excision in a Patient with Renal Cell Carcinoma

Author keywords

Complete resection; Cytoreductive therapy; Lymphadenopathy; Renal cell carcinoma; Sunitinib; Tyrosine kinase inhibitor; Unresectable

Indexed keywords

ALPHA INTERFERON; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB;

EID: 56249123229     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.09.006     Document Type: Short Survey
Times cited : (30)

References (4)
  • 1
    • 33846181370 scopus 로고    scopus 로고
    • Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    • Motzer R.J., Hutson T.E., Tomczak P., et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115-124
    • (2007) N Engl J Med , vol.356 , pp. 115-124
    • Motzer, R.J.1    Hutson, T.E.2    Tomczak, P.3
  • 2
    • 35148857486 scopus 로고    scopus 로고
    • Sunitinib efficacy against advanced renal cell carcinoma
    • Motzer R.J., Michaelson M.D., Rosenberg J., et al. Sunitinib efficacy against advanced renal cell carcinoma. J Urol 178 (2007) 1883-1887
    • (2007) J Urol , vol.178 , pp. 1883-1887
    • Motzer, R.J.1    Michaelson, M.D.2    Rosenberg, J.3
  • 3
    • 84906968245 scopus 로고    scopus 로고
    • Motzer RJ, Figlin R, Hutson TE, et al. Sunitinib versus interferon-alfa (IFN-α) as first-line treatment of metastatic renal cell carcinoma (mRCC): updated results and analysis of prognostic factors. Abstract presented at: Annual Meeting of the American Society of Clinical Oncologists; June 1-5, 2007; Chicago, IL, USA. Abstract 5024.
    • Motzer RJ, Figlin R, Hutson TE, et al. Sunitinib versus interferon-alfa (IFN-α) as first-line treatment of metastatic renal cell carcinoma (mRCC): updated results and analysis of prognostic factors. Abstract presented at: Annual Meeting of the American Society of Clinical Oncologists; June 1-5, 2007; Chicago, IL, USA. Abstract 5024.
  • 4
    • 39449121694 scopus 로고    scopus 로고
    • Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi
    • Karakiewicz P.I., Suardi N., Jeldres C., et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 53 (2008) 845-848
    • (2008) Eur Urol , vol.53 , pp. 845-848
    • Karakiewicz, P.I.1    Suardi, N.2    Jeldres, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.